← Back
$TEVA All transactions

TEVA PHARMACEUTICAL INDUSTRIES LTD

▼ SELL 10b5-1 Plan

$ Value

$700K

Shares

28,229

Price

$25

Filed

Nov 24

Insider

Name

Fox Christine

Title

EVP, Head of U.S. Commercial

CIK

0001998173

Roles

Officer

Transaction Details

Transaction Date

2025-11-20

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

63,647

Footnotes

The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. | Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. | The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2025. | Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II. | Restricted share units were granted on November 20, 2023, with 63,492 vested on each of November 20, 2024 and November 20, 2025, and 63,492 vesting on each of November 20, 2026 and November 20, 2027.

Filing Info

Accession No.

0001193125-25-293655

Form Type

4

Issuer CIK

0000818686

Fox Christine's History

Date Ticker Type Value
2026-03-05 TEVA M
2026-03-05 TEVA $251K
2026-03-05 TEVA M $0
2026-03-04 TEVA M
2026-03-04 TEVA $295K
2026-03-04 TEVA M $0
2026-03-04 TEVA A $0
2025-11-20 TEVA M
2025-11-20 TEVA $700K
2025-11-20 TEVA M $0

Other Insiders at TEVA (90d)

Insider Bought Sold Last
Francis Richard D
President and CEO
$31.1M 2026-03-05
Sabag Mark
See "Remarks"
2026-03-05
Daniell Richard
EVP, Europe Commercial
$7.7M 2026-03-05
Daniell Richard
Exec. VP, European Commercial
2026-01-27
Kalif Eliyahu Sharon
EVP, Chief Financial Officer
$11.6M 2026-03-05
Weiss Amir
Chief Accounting Officer
2026-03-05
Hughes Eric A
See "Remarks"
$3.3M 2026-03-05
Fox Christine
EVP, U.S. Commercial
$546K 2026-03-05
Shields Matthew
EVP, Global Operations
$548K 2026-03-05
Jover Placid
See "Remarks"
$448K 2026-03-05
Lippman Evan
EVP, Business Development
2026-03-04
Savage Brian
Interim Chief Legal Officer
$164K 2026-03-05